Wei, Shuanzeng https://orcid.org/0000-0002-0441-6973
Tamaki, Akina
Pei, Jianming
Vistarop, Aldana
McCue, Peter A.
Chen, Lu
Flieder, Douglas B.
Funding for this research was provided by:
NIH Office of the Director (GM150538)
Fox Chase Cancer Center
Article History
Received: 30 December 2024
Revised: 25 March 2025
Accepted: 12 April 2025
First Online: 21 April 2025
Declarations
:
: The patient in this case report was treated with standard of care; no additional diagnostic or therapeutic interventions were performed. Informed consent was obtained from the patient for the publication of this report.
: Wei is a board member of the molecular tumor board of Caris Life Sciences.